BSH 2019 | Approval of Dvd for myeloma at first relapse in the UK: impacts on care

Tanya Burton

Tanya Burton, University Hospital of Wales, Cardiff, UK, discusses the recent approval of daratumumab with bortezomib and dexamethasone for multiple myeloma at first relapse in the UK. She highlights how this will impact both patient care and day units. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK,

Share this video